Lexicon Pharmaceuticals, Inc. (LXRX) has a consensus analyst rating of Hold, based on 14 analysts covering the stock. Of those, 5 recommend buying, 7 recommend holding, and 2 recommend selling.
The analyst consensus price target for LXRX is $6.00, representing a +242.9% upside from the current price of $1.75. Price targets range from a low of $6.00 to a high of $6.00.
